DYNT $1.25 COULD BE AN EASY DOUBLE....CHECK IT OUT
SAFE INVESTMENT. STRONG PROFITABLE 2007 PREDICTED. STOCK BUYBACK ONGOING. LOW FLOAT. MANY NEW PRODUCTS LAUNCHED AND TO BE LAUNCHED. STRONG BALANCE SHEET. TRADING AT 0.5/P/S.
EARNINGS IN 4 WEEKS.
6-month Target:$3
Dynatronics (Nasdaq: DYNT) recently reported another profitable year for FY 2006. 2007 is looking like it will be a strong year for DYNT.
DYNT's CEO predicted at least 10% revenue growth and a substantial increase in net income.....1Q 2007 will be reported in about 6 weeks.
From the earnings release and CC:
-- DYNT was profitable again. The company invested an all-time record amount in R&D in 2006.
-- The positive effect of the many new products launched, and to be launched in the next few weeks, on revenues and net income will start showing up in Q1 2007 to be reported in early November 2006.
-- DYNT will lower R&D expenses by about 5c/share in 2007 from 2006's record levels.
DYNT HIGHLIGHTS:
* DYNT IS THE LEADER IN LIGHT THERAPY FOR PAIN MANAGEMENT
* FDA APPROVED and PATENTED PRODUCTS
* NEW PRODUCTS WILL YIELD SUBSTANTIAL GAINS IN REVENUE AND NET INCOME STARTING with 1Q 2007
* PROFITABLE AND TRADING AT 0.5 P/S
* STRONG BALANCE SHEET
* STOCK BUYBACK IS ONGOING.
-- The company believes the stock is undervalued and has triggered its stock-buyback program. About 50K shares have been purchased in the open market in 2006. DYNT has cash authorized to buy 250K more shares. the company activates its buyback program when the stock dips under $1.3.
-- Two major new products will be launched in October/November 2006.
-- Based on the new product launches and reduced R&D costs, DYNT expects at least a 10% revenue growth and substatially higher net income. I believe net income will range from 10 -15c/share in 2007.
SELECTED COMPANY COMMENTS FROM 2006 EARNINGS RELEASE and CC
..."New products introduced during the past year include the Dynatron 702, a stand-alone light therapy device, as well as the new DX9 combination traction and light therapy system. The DX9 system combines the benefits of infrared light therapy using the Dynatron 702 with decompression therapy using the Company's TX900 Traction device. This unique combination of modalities has been reported to be highly effective in the treatment of back pain..."
"Dynatronics also introduced the Dynatron Xp light pad in 2006. This popular product is capable of treating a much larger area than can be treated by other devices. It is 14 times more powerful than light probes currently on the market and makes unattended patient therapy possible..."
"Looking ahead to fiscal 2007, we are pleased to have begun the year with the July 2006 introduction of the new Dynatron X3 infrared light therapy device," said Larry K. Beardall, executive vice president for sales and marketing. "In addition, we plan to introduce the much anticipated DX2 proprietary traction device soon. The DX2 incorporates patent-pending technology and will utilize the new T4 treatment table which is specially designed for traction and decompression therapies. The T4 treatment table is scheduled for introduction in November 2006."
The new DX2 is currently undergoing clinical beta testing and has been previewed at several national trade shows. "Interest in the DX2 from practitioners at the national trade shows has been substantial," reported Beardall. "While the development effort has taken longer than anticipated, we believe this innovative approach to treating back pain will prove to be a great benefit to patients."
ABOUT DYNT:
DYNT is the leader in the area of light therapy for pain management. DYNT's Light therapy products are FDA-approved. In fact, it was widely publicized that one of Dynatronics' light therapy probes was use to accelerate Terrel Owens' amazing recovery in time to play in the Superbowl a couple of years ago.
Because light therapy is non-invasive and does not have adverse effects, it is an ideal replacement for dangerous drugs like Vioxx, and Celebrex to address Rheumatism and similar types of pain. Light therapy is also used for carpal syndrome and a number of muscle/nerve/bone types of pain.
Light Therapy has been used extensively throughout the world for more than twenty years. Also known as cold laser or phototherapy, Light Therapy is backed by extensive research with over 500 published studies covering a number of soft-tissue injuries, pain, and inflammatory conditions.
AI
